ClinicalTrials.gg
Status unknownNCT02815215Updated Jun 28, 2016

Efficacy Analysis of Minimally Invasive Carroll's Technique in Treatment of Congenital Idiopathic Clubfoot

An Early Phase 1 interventional study of Minimally Invasive Carroll's Technique and Ponseti method in Congenital Clubfoot, sponsored by LiMing. Status unknown at 1 site in China. Open to participants aged 28 Days to 4 Years. Per ClinicalTrials.gov, last updated 2016-06-28.

Sponsored by LiMing · Early Phase 1, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jun 2016), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Early Phase 1
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
28 Days to 4 Years
Sex
All
01

Study summary

Congenital clubfoot(CCF) is a kind of common congenital foot deformities in children. Though Ponseti method can cure most of the CCF patients, there are still part of patients can not get satisfactory recovery, especially those children classified as Dimeglio grade Ⅲ and Ⅳ. Carroll's technique is considered to be an ideal method of surgical treatment. But the postoperative scar is relatively large, and accordingly the postoperative complications is still common. Based on the clinical practice of the investigator's group, a modification of Carroll's technique, minimally invasive Carroll's technique, was applied. For the Dimeglio grade Ⅲ and Ⅳ CCF, the postoperative excellent and good rate was over 90%. Therefore, the investigator conducted a multicenter randomized controlled trial on treatment of congenital idiopathic clubfoot with minimally invasive Carroll's technique.

02

Conditions studied

  • Congenital Clubfoot

Browse trials for

Keywords

  • congenital clubfoot
03

In context

Clubfoot

69 studies on the registry are indexed under Clubfoot; 15 are open to participants now.

This study's planned enrollment of 80 is above the median of 38 across 40 interventional studies indexed under Clubfoot.

Browse Clubfoot studies →

Lead sponsor

This is the only study on the registry with LiMing as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
28 Days to 4 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • First diagnosed congenital idiopathic clubfoot cases classified as Dimeglio grade Ⅲ and Ⅳ

Exclusion criteria

Exclusion Criteria:

  • Age≤28 days, and Age>4 years.
  • Accompanied by serious diseases of other organs.
  • Children with inherited metabolic disease and connective tissue disease.
  • Clubfoot caused by trauma, cerebral palsy, congenital multiple joint contracture, polio, spina bifida occulta, and clubfoot derived from spinal cord disease.
05

Study design

Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Minimally Invasive Carroll's Technique

    Procedure: Minimally Invasive Carroll's Technique

  • Active comparator
    Control group

    Ponseti method

    Procedure: Ponseti method

Interventions

  • ProcedureMinimally Invasive Carroll's Technique

    Patient will be treated with minimally invasive Carroll's technique by 3 small incisions in the heel, in the medial side of the foot and in the planta pedis, respectively. Long-leg plaster cast fixation was applied for 6-8 weeks

  • ProcedurePonseti method

    As a control, Patient will be treated with classical Ponseti method, including multiple steps: manipulative correction, continuous plaster, achilles tendon cutting, fixation.

06

What researchers measure

Primary outcomes

  1. Dimeglio classification system

    evaluate the grade before and after treatment

    Time frame: 0 month(before treatment); 3rd month, 1st year, 3rd year(after treatment)

Secondary outcomes

  1. Pirani scoring system

    evaluate the grade before and after treatment

    Time frame: 0 month(before treatment); 3rd month, 1st year, 3rd year(after treatment)

Other outcomes

  1. talocalcaneal angle measurement

    evaluate the grade before and after treatment

    Time frame: 0 month(before treatment); 3rd month, 1st year, 3rd year(after treatment)

07

Study locations

1 of 1 sites recruiting
  • Children's Hospital of Chongqing Medical University
    Chongqing, Chongqing 400014, China
    Recruiting
    • Zhu Yu, bachelor · Contact86-13752899331
08

References and documents

Publications

  • Carroll NC. Clubfoot in the twentieth century: where we were and where we may be going in the twenty-first century. J Pediatr Orthop B. 2012 Jan;21(1):1-6. doi: 10.1097/BPB.0b013e32834a99f2. PubMed 21946867 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jun 2016, a primary completion of Dec 2016 and a completion of Dec 2019. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 21, 2016
First posted
Jun 28, 2016
Start
Jun 2016
Primary completionEst.
Dec 2016
CompletionEst.
Dec 2019
Last update
Jun 28, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 28, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02815215
Lead sponsor
LiMing
Collaborators
Hunan Children's Hospital, Shenzhen Children's Hospital, Guangzhou Women and Children's Medical Center
Responsible party
LiMing (Chief of Pediatric Orthopedics, Children's Hospital of Chongqing Medical University) — Sponsor-investigator
First posted
Jun 28, 2016
Start date
Jun 2016
Primary completion
Dec 2016 (estimated)
Completion
Dec 2019 (estimated)
Last update
Jun 28, 2016

Study contacts

Ming Li, master
Contact
lm3180@163.com
86-023-63633321
Hang Liu, doctorate
Contact
liuhcq@yeah.net
86-15923384065
Ming Li, master
principal investigator · Children's Hospital of Chongqing Medical University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion